Interactions among tumor subtype, PPARγ expression, and adipose proliferation shape outcomes in breast cancer.

For this study, statistical significance was indicated by p ‐values <0.05, and marginally significant results have p ‐values >0.05 but <0.10.

also in 26,082 other papers

In the premenopausal cohort, across tumor receptor types (HER2‐negative, ER+, TNBC), patients with low PPARγ expression have lower survival, especially in the ER+ and TNBC cohorts where there is marginal significance; in the HER2‐negative cohort, there are minimal differences across the two groups (Figure 2b,e,h ).

also in 5,069 other papers